期刊文献+

胺碘酮联合血管紧张素Ⅱ受体拮抗剂在心房颤动复律后维持窦性心律临床观察

原文传递
导出
摘要 目的:观察胺碘酮联合应用血管紧张素Ⅱ受体拮抗剂(ARB)在心房颤动复律后维持窦性心律的疗效。方法:85例持续性心房颤动的患者,药物或电复律后随机分为两组,Ⅰ组43例,单纯口服胺碘酮,Ⅱ组42例口服胺碘酮联合应用血管紧张素Ⅱ受体拮抗剂,观察12个月。结果:79例完成治疗。Ⅱ组窦性心律维持率明显高于Ⅰ组,有统计学差异。结论:胺碘酮联合应用血管紧张素Ⅱ受体拮抗剂较单用胺碘酮更有效。
作者 郭华
出处 《中国误诊学杂志》 CAS 2009年第15期3577-3578,共2页 Chinese Journal of Misdiagnostics
  • 相关文献

参考文献2

二级参考文献16

  • 1Wachtell K,Lehto M, Hornestam B, et al. Losartan reduces the risk of new-onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy:the LIFE studv[J]. Eur Heart J, 2003, 24:504.
  • 2Finkielstein D,Schweitzer P. Role of angiotensin-oonverting enzyme inhibitors in the prevention of atrial fibrillation[J]. Am J Cardiol,2004,93:734-736.
  • 3Swedberg K, Pfeffer M, Coen-Solal A, et al. Prevention of atrial fibrillation in symptomatic chronic heart failure by candesartan:resuhs from the CHARM study[J]. J Am Coll Cardiol,2004,43 ( suppl A ) : 222 A.
  • 4Swedberg K, Pfeffer M, Coen-Solal A, et al. Prevention of atrial fibrillation in symptomatic chronic heart failure by candesartan:resuhs from the CHARM study[abstract][J]. J Am Coll Cardiol,2004,43 ( suppl A ) :222 A.
  • 5Teo K,Yusuf S,Anderson C,et al.Rationale ,design,and baseline characteristics of 2 large,simple randomized trials evaluating telmisartan,ramipril and their combination in high-risk patients:The ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment in ACE intolerant subjects with cardiovascular disease[J].Am Heart J,2004,148:52-61.
  • 6Zaman AG, Kearney MT, Schecter C, et al. Angiotensin-converting enzyme inhibitors as adjuvent therapy in patients with persistent atrial fibrillation [J]. Am Heart J ,2004,147 : 823-827.
  • 7Kumagai K, Nakashima H, Urata H ,et al. Effects of angiotensin Ⅱ type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation [J]. J Am Coll Cardiol,2003,41:2197-2204.
  • 8Goette A, Staack T, Rocken C, et al. Increased expression of extracellular signalregulated kinase and angiotensin-converting enzyme in human atrial during atrial fibrillation[J]. J Am Coll Cardiol,2000,35 : 1669-1677.
  • 9Goette A,Arndt M ,Rocken C, et al. Regulation of angiotensin Ⅱ receptor subtypes during atrial fibrillation in humans[J]. Circulation, 2000,101 : 2678-2681.
  • 10Li D, Shinagawa K, Pang L, et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure[J]. Circulation, 2001,104 :2608-2614.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部